This study demonstrates the utility of a network approach in deepening the understanding of the structure of CG symptoms among Chinese older people. Strengths and limitations, as well as implications for informing the assessment and treatment of this disorder, were discussed. BACKGROUND Non-motor symptoms (NMS) are common in Parkinson's disease (PD), but their relationships to nigrostriatal degeneration remain largely unexplored. METHODS We evaluated 18 NMS scores covering 5 major domains in relation to concurrent and future dopamine transporter (DAT) imaging in 344 PD patients from the Parkinson's Progression and Markers Initiative (PPMI). We standardized NMS assessments into z-scores for side-by-side comparisons. Patients underwent sequential DaTSCAN imaging at enrollment and at months 12, 24, and 48. Specific binding ratios (SBR) were calculated using the occipital lobe reference region. We evaluated the association of striatal DAT binding at the four time points with each baseline NMS using mixed-effects regression models. RESULTS Multiple baseline NMS were significantly associated with DAT binding at baseline and at follow-up scans. REM sleep behavior disorder (RBD) symptoms showed the strongest association - mean striatal SBR declined with increasing RBD symptom z-score (average of time-point-specific slopes per unit change in z-score βAVG&nbsp;=&nbsp;-0.083, SE&nbsp;=&nbsp;0.017; p&nbsp; less then &nbsp;0.0001). In addition, striatal DAT binding was linearly associated with increasing baseline z-scores positively for the memory (βAVG=0.055, SE&nbsp;=&nbsp;0.022; p&nbsp;=&nbsp;0.01) and visuospatial (βAVG=0.044, SE&nbsp;=&nbsp;0.020; p&nbsp;=&nbsp;0.03) cognitive domains, and negatively for total anxiety (βAVG= -0.059, SE&nbsp;=&nbsp;0.018; p&nbsp;=&nbsp;0.001). Striatal DAT binding showed curvilinear associations with odor identification, verbal discrimination recognition, and autonomic dysfunction z-scores (p&nbsp;=&nbsp;0.001, p&nbsp;=&nbsp;0.0009, and p&nbsp;=&nbsp;0.0002, respectively). Other NMS were not associated with DAT binding. CONCLUSIONS Multiple NMS, RBD symptoms in particular, are associated with nigrostriatal dopaminergic changes in early PD. Small-angle X-ray scattering (SAXS) method is widely used in investigating protein structures in solution, but high-quality 3D model reconstructions are challenging. We present a new algorithm based on a deep learning method for model reconstruction from SAXS data. An auto-encoder for protein 3D models was trained to compress 3D shape information into vectors of a 200-dimensional latent space, and the vectors are optimized using genetic algorithms to build 3D models that are consistent with the scattering data. The program has been tested with experimental SAXS data, demonstrating the capacity and robustness of accurate model reconstruction. Furthermore, the model size information can be optimized using this algorithm, enhancing the automation in model reconstruction directly from SAXS data. The program was implemented using Python with the TensorFlow framework, with source code and webserver available from http//liulab.csrc.ac.cn/decodeSAXS. Mammalian brain development critically depends on proper thyroid hormone signaling, via the TRα1 nuclear receptor. The downstream mechanisms by which TRα1 impacts brain development are currently unknown. In order to investigate these mechanisms, we used mouse genetics to induce the expression of a dominant-negative mutation of TRα1 specifically in GABAergic neurons, the main inhibitory neurons in the brain. This triggered post-natal epileptic seizures and a profound impairment of GABAergic neuron maturation in several brain regions. Analysis of the transcriptome and TRα1 cistrome in the striatum allowed us to identify a small set of genes, the transcription of which is upregulated by TRα1 in GABAergic neurons and which probably plays an important role during post-natal maturation of the brain. Thus, our results point to GABAergic neurons as direct targets of thyroid hormone during brain development and suggest that many defects seen in hypothyroid brains may be secondary to GABAergic neuron malfunction. Honeycomb-layered phases Na3M2XO6 (M&nbsp;= Ni, Cu, Co; X&nbsp;= Sb, Bietc.) have been intensively pursued as high-voltage and high-rate capability cathode materials for Na-ion batteries (NIBs), but the crystal structure is not well elucidated. Herein, structural analysis was conducted on pristine Na3Ni2SbO6 material using electron microscopy and associated spectroscopies to reveal its crystallographic features. Experimental observations along multiple zone axes indicate that structural disorder is intrinsic in the pristine Na3Ni2SbO6, characteristic of randomly stacked layers with three variants of monoclinic structure. Stacking disorder is demonstrated by the non-vertical relationship of adjacent Ni2SbO6 layers in [100] zone axis, the different Ni/Sb atomic arrangements in [010] zone axis, and the Ni/Sb random overlap in [001] zone axis. The insight on the structural disorder may inspire studies on their phase transformations upon cycling and provide some clues to potentially solve the voltage/capacity decay problems of these honeycomb-layered materials. Emerging evidence demonstrates that radiotherapy induces immunogenic death on tumor cells that emit immunostimulating signals resulting in tumor-specific immune responses. However, the impact of tumor features and microenvironmental factors on the efficacy of radiation-induced immunity remains to be elucidated. Herein, we use a calibrated model of tumor-effector cell interactions to investigate the potential benefits and immunological consequences of radiotherapy. Simulations analysis suggests that radiotherapy success depends on the functional tumor vascularity extent and reveals that the pre-treatment tumor size is not a consistent determinant of treatment outcomes. The one-size-fits-all approach of conventionally fractionated radiotherapy is predicted to result in some overtreated patients. In addition, model simulations also suggest that an arbitrary increase in treatment duration does not necessarily result in better tumor control. https://www.selleckchem.com/products/yap-tead-inhibitor-1-peptide-17.html This study highlights the potential benefits of tumor-immune ecosystem profiling during treatment planning to better harness the immunogenic potential of radiotherapy.